The acceptance of COVID-19 vaccines in Rwanda

• Verfasst von: Mbonigaba, Edward [VerfasserIn]
• Verfasst von: Yu, Fengyun [VerfasserIn]
• Verfasst von: Reñosa, Mark Donald [VerfasserIn]
• Verfasst von: Mwikarago, Ivan Emil [VerfasserIn]
• Verfasst von: Cho, Frederick Nchang [VerfasserIn]
• Verfasst von: Elad, Peter Canisius Kuku [VerfasserIn]
• Verfasst von: Metzger, Wolfram [VerfasserIn]
• Verfasst von: Muhindo, Richard [VerfasserIn]
• Verfasst von: Chen, Qiushi [VerfasserIn]
• Verfasst von: Denkinger, Claudia M. [VerfasserIn]
• Verfasst von: McMahon-Rössle, Shannon A. [VerfasserIn]
• Verfasst von: Chen, Simiao [VerfasserIn]
• Titel: The acceptance of COVID-19 vaccines in Rwanda
• Titelzusatz: a cross-sectional study
• Verf.angabe: Edward Mbonigaba, Fengyun Yu, Mark Donald C. Reñosa, Ivan Emil Mwikarago, Frederick Nchang Cho, Peter Canisius Kuku Elad, Wolfram Metzger, Richard Muhindo, Qiushi Chen, Claudia M. Denkinger, Shannon A. McMahon and Simiao Chen
• E-Jahr: 2024
• Jahr: 18 October 2024
• Umfang: 12 S.
• Illustrationen: Illustrationen
• Fussnoten: Gesehen am 11.04.2025
• Titel Quelle: Enthalten in: BMC public health
• Ort Quelle: London : BioMed Central, 2001
• Jahr Quelle: 2024
• Band/Heft Quelle: 24(2024), Artikel-ID 2875, Seite 1-12
• ISSN Quelle: 1471-2458
• DOI: doi:10.1186/s12889-024-20417-9
• Datenträger: Online-Ressource
• Sprache: eng
• Sach-SW: Acceptability
• Sach-SW: COVID-19
• Sach-SW: Rwanda
• Sach-SW: Vaccination
• Sach-SW: Vaccine acceptance
• K10plus-PPN: 1922586692

Abstract

The first reported case of Coronavirus Disease 2019 (COVID-19) in Rwanda occurred on March 14 2020. By the end of July 2024, a total of 133,518 individuals had tested positive for the infection, resulting in 1,468 deaths and 132,039 had fully recovered. The success of COVID-19 elimination in Rwanda hinges on the public’s level of acceptance of the COVID-19 vaccination. Although COVID-19 is no longer a pandemic anymore, the World Health Organisation recommends countries vaccinate their populations to protect them from COVID-19 and its variants. Globally, COVID-19 has affected 704,753,890 people, caused 7,010,681 deaths and 675,619,811 have recovered. This study aimed to assess the acceptability of COVID-19 vaccines among adults aged 18 years and above in Rwanda. A cross-sectional study was conducted from January to March 2022 to determine the associations between COVID-19 vaccine acceptance (VA) with respondents’ characteristics, using logistic regression analysis. This study enrolled 2,126 respondents with a mean age of 31 years, the majority of whom were females (82.2%), 51.4% had completed primary education, and 78.7% were married. Most respondents recognized the importance of COVID-19 vaccination for both personal health and community well-being. The study found a high rate of COVID-19 vaccine acceptance, with 91.6% of respondents expressing VA and an overall VA rate of 98.2%. Having a relationship with the child(ren) was the only characteristic associated with COVID-19 vaccine acceptance (p; 3.2 × 10− 3, OR; 2.9, 95% C.I; 1.4-5.9). In conclusion, the study found a high rate of COVID-19 vaccine acceptance among adults in Rwanda, with COVID-19 associated with having a relationship with the child(ren). The study recommends the need for mass educational campaigns and awareness-raising efforts to understand of COVID-19 vaccines.